MARKET

PPH

PPH

VanEck Vectors Pharmaceutical ETF
NASDAQ

Real-time Quotes | Provided by Morningstar

66.06
-1.16
-1.73%
Closed 16:00 03/04 EST
OPEN
66.70
PREV CLOSE
67.22
HIGH
67.06
LOW
65.24
VOLUME
154.69K
TURNOVER
--
52 WEEK HIGH
71.15
52 WEEK LOW
46.90
TOTAL ASSET
177.87M
YTD YIELD
-1.48%
1D
5D
1M
3M
1Y
5Y
Yes, Bond ETFs Can Go Haywire. But That’s a Good Thing, Says BIS
Critics of the passive-investing boom in bonds warn about the risks stemming from the mismatch between highly tradable ETFs and the illiquid securities they hold.
Bloomberg · 3d ago
As a Treasuries Rout Went Global, China’s Bonds Shone on Alone
As investors fled almost every fixed-income asset from the safest government bonds to the highest-yielding securities last week, one market stood out as a haven.
Bloomberg · 3d ago
Cathie Wood’s Power in Some Stocks Is Even Bigger Than It Seems
A rough week for Cathie Wood is reminding Wall Street that Ark Investment Management has a lot of cash in not that many companies. In fact, the firm’s dominance in some stocks may be even greater than it seems.
Bloomberg · 5d ago
Pharma ETFs in Focus Post Q4 Earnings
Zacks.com · 02/05 17:40
Short-Squeezed Hedge Funds Are Now Getting Hit on Their Bullish Bets Too
Bloomberg · 01/26 23:10
SPAC Boom Heats Up as Latest Blank-Check ETF Hits the Market
There’s a new exchange-traded fund tracking the hot trend of blank-check companies.
Bloomberg · 01/26 18:57
Psychedelics ETF, World’s First, Seizes on Mental Health Uses
The world’s first exchange-traded fund solely for psychedelic-drug companies will debut this week in Toronto, a reflection of the investment industry’s desire to capitalize on rising interest in prospective mental health treatments using the drugs.
Bloomberg · 01/26 16:19
Dot-com Era Stock Valuations Bringing Bubble Fear to ESG Funds
It’s reality-check time for ESG funds.
Bloomberg · 01/26 05:00
More
No Data
Learn about the latest financial forecast of PPH. Analyze the recent business situations of VanEck Vectors Pharmaceutical ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-2.1712%
--
1-Week
-2.4151%
--
1-Month
-2.9895%
--
3-Month
-1.3098%
--
6-Month
4.8724%
--
YTD
-1.4781%
--
1-Year
12.4328%
--
3-Year
5.9871%
--
5-Year
0.5642%
--
Since Inception
8.8357%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
VanEck Vectors Pharmaceutical ETF
Risk
Medium-low risk
Inception Date
2011-12-20
Benchmark
Dow Jones US Healthcare TR
Advisor Company
VanEck
Custodian
State Street Bank & Trust Co
Manager
Liao/Jin